Zobrazeno 1 - 9
of 9
pro vyhledávání: '"B Marmesat Rodas"'
Publikováno v:
European Journal of Hospital Pharmacy. 22:A138.4-A139
Background Pure red cell aplasia is a severe, non-regenerative form of anaemia, with selective erythroid aplasia of the bone marrow. Although there are congenital forms, most cases are adquired by toxic, radiation or drugs and 50% are idiopathic. Pur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4df5448d0452e7d0d2950b0e73d1d56f
https://doi.org/10.1136/ejhpharm-2015-000639.333
https://doi.org/10.1136/ejhpharm-2015-000639.333
Autor:
D Guerra Estévez, JC Roldán, E Campos-Davila, E Marquez-Fernandez, JJ Ramos-Báez, B Marmesat Rodas
Publikováno v:
European Journal of Hospital Pharmacy. 22:A54.1-A54
Background Pharmacists prescribe and monitor, in consensus with Oncology, individualised Post-Chemotherapy antiemetic regimes for all patients in our Hospital. Purpose To evaluate the quality and the acceptance of the antiemetic treatment prescribed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24e6cc62e0de8149f0e9422215c7d3f3
https://doi.org/10.1136/ejhpharm-2015-000639.129
https://doi.org/10.1136/ejhpharm-2015-000639.129
Autor:
V. Faus Felipe, B. Marmesat Rodas, ME Blanco Rivas, Jimena Abilés, JJ Arenas Villafranca, R Romero Dominguez
Publikováno v:
Clinical Nutrition. 32:S204-S205
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00a34524668a991270b176a2a9c7f368
https://doi.org/10.1016/s0261-5614(13)60532-4
https://doi.org/10.1016/s0261-5614(13)60532-4
Publikováno v:
European Journal of Hospital Pharmacy. 21:A93.2-A94
Background Dapsone is an antileprotic whose mechanism of action for linear IgA dermatosis is not yet known. Purpose To evaluate the efficacy and safety of dapsone in the treatment of linear IgA dermatosis in a paediatric patient. Materials and method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::361346d1056c780060e55ebfbbb6a724
https://doi.org/10.1136/ejhpharm-2013-000436.229
https://doi.org/10.1136/ejhpharm-2013-000436.229
DI-043 Appropriateness of telaprevir treatment in patients with chronic hepatitis C virus genotype 1
Publikováno v:
European Journal of Hospital Pharmacy. 21:A87.2-A88
Background The length of treatment with triple therapy against hepatitis C virus genotype 1 (HCV-1), which comprises telaprevir, ribavirin and peginterferon α-2b, is variable, depending on the patient to be treated. Purpose To evaluate the use and e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad1c1470888954f79867af707ba0f207
https://doi.org/10.1136/ejhpharm-2013-000436.214
https://doi.org/10.1136/ejhpharm-2013-000436.214
Autor:
MP Quesada Sanz, JJ Ramos Báez, M. Gallego Galisteo, F. Téllez Pérez, J.C. Roldán Morales, B Marmesat Rodas
Publikováno v:
European Journal of Hospital Pharmacy. 19:121.3-122
Background Reconciliation of discrepancies in the patient9s treatment may improve the quality of healthcare in a population susceptible to drug errors. Purpose To analyse differences detected in home treatment after hospital discharge for polymedicat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ba481e5369effcd03a1a6a2d607656d
https://doi.org/10.1136/ejhpharm-2012-000074.97
https://doi.org/10.1136/ejhpharm-2012-000074.97
Autor:
E Márquez Fernández, E. Campos Dávila, J.R. Ávila Álvarez, M. Gallego Galisteo, F. Téllez Pérez, B Marmesat Rodas
Publikováno v:
European Journal of Hospital Pharmacy. 19:121.2-121
Background The accumulation of drugs can cause errors in taking the medicines and an unnecessary increase in health expenditure. Purpose To quantify the accumulation of drugs in the home medicines cabinets of polymedicated patients aged over 64 and t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e4bc4a80800899a149d86cca0907c0a
https://doi.org/10.1136/ejhpharm-2012-000074.96
https://doi.org/10.1136/ejhpharm-2012-000074.96
Publikováno v:
European Journal of Hospital Pharmacy. 19:174.3-175
Background The use of calcium and magnesium reduces both the incidence and time of development of peripheral sensory neurotoxicity, oxaliplatin-limiting toxicity. Purpose To determine the effectiveness of calcium gluconate and magnesium sulphate in p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33a9ebf1c6a480cfc4a1bf17cfa75396
https://doi.org/10.1136/ejhpharm-2012-000074.236
https://doi.org/10.1136/ejhpharm-2012-000074.236
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.